Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society
Open accessThe DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Neuropathic pain (NeP), redefined as pain caused by a lesion or a disease of the somatosensory system, is a disabling condition that affects approximately two million Canadians. OBJECTIVE: To review the randomized controlled trials (RCTs) and systematic reviews related to the pharmacological management of NeP to develop a revised evidence‐based consensus statement on its management. METHODS: RCTs, systematic reviews and existing guidelines on the pharmacological management of NeP were evaluated at a consensus meeting in May 2012 and updated until September 2013. Medications were recommended in the consensus statement if their analgesic efficacy was supported by at least one methodologically sound RCT (class I or class II) showing significant benefit relative to placebo or another relevant control group. Recommendations for treatment were based on the degree of evidence of analgesic efficacy, safety and ease of use. RESULTS: Analgesic agents recommended for first‐line treatments are gabapentinoids (gabapentin and pregabalin), tricyclic antidepressants and serotonin noradrenaline reuptake inhibitors. Tramadol and controlled‐release opioid analgesics are recommended as second‐line treatments for moderate to severe pain. Cannabinoids are now recommended as third‐line treatments. Recommended fourth‐line treatments include methadone, anticonvulsants with lesser evidence of efficacy (eg, lamotrigine, lacos‐amide), tapentadol and botulinum toxin. There is support for some analgesic combinations in selected NeP conditions. CONCLUSIONS: These guidelines provide an updated, stepwise approach to the pharmacological management of NeP. Treatment should be individualized for each patient based on efficacy, side‐effect profile and drug accessibility, including cost. Additional studies are required to examine head‐to‐head comparisons among analgesics, combinations of analgesics, long‐term outcomes and treatment of pediatric, geriatric and central NeP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Results from both the scientific literature and public media revealed few references to nabilone abuse.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, nabilone theft did occur, although nabilone has no known street value.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“According to the literature, the positive side effects (euphoria, mood elevation) of nabilone, which may lead to abuse, generally occurred less frequently than the negative side effects (drowsiness, dizziness, and dry mouth).”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the public media, patients described nabilone as not producing the same therapeutic and recreational effects as smoked cannabis.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Overall, the authors concluded that nabilone is rarely abused or diverted.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Bouhassira, D., Attal, N., Alchaar, H., Boureau, F., Brochet, B., Bruxelle, J., Cunin, G., Fermanian, J., Ginies, P., Grun-Overdyking, A., et al. (2005) · Pain · doi:10.1016/j.pain.2004.12.010 · Cited by 2,741
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Prevalence of chronic pain with neuropathic characteristics in the general population
Bouhassira, D., Lantéri-Minet, M., Attal, N., Laurent, B., & Touboul, C. (2008) · Pain · doi:10.1016/j.pain.2007.08.013 · Cited by 1,745
Algorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,330
Effects of Desipramine, Amitriptyline, and Fluoxetine on Pain in Diabetic Neuropathy
Max, M. B., Lynch, S. A., Muir, J., Shoaf, S. E., Smoller, B., & Dubner, R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205073261904 · Cited by 1,117
The evidence for pharmacological treatment of neuropathic pain
Finnerup, N. B., Sindrup, S. H., & Jensen, T. S. (2010) · Pain · doi:10.1016/j.pain.2010.06.019 · Cited by 1,045
Smith, E. M. L., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., Bressler, L. R., Fadul, C. E., Knox, C., Le-Lindqwister, N., et al. (2013) · JAMA · doi:10.1001/jama.2013.2813 · Cited by 1,014
Torrance, N., Smith, B. H., Bennett, M. I., & Lee, A. J. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2005.11.008 · Cited by 1,000
A systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramér, M., Nye, B. A., Carroll, D., Wiffen, P. J., & Moore, R. A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 930
Research works printed but not linked: 1
- [20]Cohen J Statistical Power Analysis for the Behavioural Sciences New York, San Francisco, London Academic Press 1988
Cited by
Items 401–500 of 529
Pharmacological Approach to Atypical Odontalgia Patients: A Systematic Review of Case Reports
Siregar, Y. D., Putri, F. A., & Maulina, T. (2022) · The Open Dentistry Journal · doi:10.2174/18742106-v16-e2201120 · Cited by 3
Traitements topiques et douleur neuropathique localisée chez la personne âgée
Morel, V., & Pickering, G. P. (2022) · Douleurs Évaluation - Diagnostic - Traitement · doi:10.1016/j.douler.2022.02.005 · Cited by 1
Defining the position of rehabilitation in the management of degenerative cervical myelopathy
Loh, E., Gholamrezaei, G., Alison, D., Ahrens, J., Curt, A. E. P., & Kalsi‐Ryan, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95334-4.00001-2 · Cited by 1
Mistry, J., Walton, D. M., Noblet, T., Bowling, B., Heneghan, N. R., & Rushton, A. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-078392 · Cited by 2
Empleo empírico de cannabis para control del dolor crónico de origen musculoesquelético
Guevara‐López, U., Elizarrarás-Rivas, J., Ramirez-Garcia, S. A., Hernández-Sosa, V., Hoyos-Bermea, A. D., González-Sánchez, J. Á., & Viguri-Castellanos, R. F. (2024) · Revista Mexicana de Anestesiología · doi:10.35366/115316 · Cited by 1
Advances in neuropathic pain management: A review of real-world studies
Dash, S. S., Khatri, N. K., Divyateja, S., Bhate, J., & Rao, G. K. S. (2024) · Journal of Current Research in Scientific Medicine · doi:10.4103/jcrsm.jcrsm_132_23 · Cited by 6
Zheng, H., & Zheng, B. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1422778 · Cited by 1
Analgesic medication considerations for chronic pain management post-bariatric surgery
Vij, S., Too, A., Tsang, V., & Kreutzwiser, D. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2398631 · Cited by 1
Desafíos del tratamiento del dolor con el VIH y terapias alternativas
Mello, A., & Gravel, T. (2017) · Nursing (Ed española) · doi:10.1016/j.nursi.2017.11.017 · Cited by 1
Prophylaxe und Therapie der chemotherapieinduzierten Polyneuropathie
Koeppen, S. (2018) · best practice onkologie · doi:10.1007/s11654-018-0082-x · Cited by 2
Current and Emerging Payment Models for Spine Pain Care: Evidence-Based, Outcomes-Based, or Both?
Williams, K., & Carr, D. B. (2019) · Springer eBooks · doi:10.1007/978-3-030-27447-4_3 · Cited by 1
Murphy, L. L., Brands, B., Grant, D., Smith, A., Zhang, M., & Sproule, B. A. (2020) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-020-01027-y · Cited by 2
Sahni, S., & Khan, J. S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96546 · Cited by 2
Сучасні аспекти диференціальної діагностики й лікування хронічного болю в нижній частині спини
Kopchak, O. O. (2022) · INTERNATIONAL NEUROLOGICAL JOURNAL · doi:10.22141/2224-0713.17.8.2021.250816 · Cited by 2
Cannabinoid-based medications for pain
Marie, R. M. S. (2021) · Current Psychiatry · doi:10.12788/cp.0121 · Cited by 1
Cannabinoid-Based Medicines and Cancer Symptom Management
Daeninck, P. J., Rudney, R., & Davis, M. P. (2022) · Springer eBooks · doi:10.1007/978-3-030-89918-9_5 · Cited by 1
Chronic back pain from rheumatologist point of view
Olyunin, Y. A., & Lila, A. M. (2022) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2022-5-94-100 · Cited by 1
Manejo de Espondilolistesis degenerativa lumbar: revisión bibliográfica.
Dias-Dias, J. E., & Chimbo, P. F. T. (2023) · MQRInvestigar · doi:10.56048/mqr20225.7.3.2023.3119-3136 · Cited by 2
Parsons, B., Martire, D. L., Jorga, A., & Donevan, S. D. (2018) · Neurology · doi:10.1212/wnl.0000000000005675 · Cited by 1
Dezocine attenuates neuropathic pain by inhibiting ERK1/2 signaling in ratsPreprint
Shen, C., Sheng, S., Yu, L., & Xin, N. (2019) · doi:10.21203/rs.2.12507/v1 · Cited by 1
Scientific Program Directors and Residency Research Coordinators
Gilron, I., Jaeger, M. T., Allard, R. V., Hare, G., Parlow, J. L., Cummings, M., Asselstine, K., Wang, L., & Phelan, R. (2013)
Self-citationLacosamida en el tratamiento del dolor neuropático
Montero, A. A., & Curado, A. G. (2016) · Revista de la Sociedad Española del Dolor · doi:10.20986/resed.2016.3423/2016
Pharmacotherapyofneuropathicpain:whichdrugs, which treatment algorithms?
Attal, N., & Bouhassira, D. (2015)
Adjuvant Agents in Chronic Pain Therapy
Pergolizzi, J. V. (2016) · Springer eBooks · doi:10.1007/978-3-319-30964-4_8 · Cited by 1
Déry-Neveu, B., & Fournier-Tondreau, M. (2016) · Pharmactuel
Antidepressant and Anticonvulsant Drugs as Adjuvant Analgesics in Chronic Pain
Sebastián-Aldeanueva, M., López‐Muñoz, F. J., Guerra, J. A., & Álamo, C. (2016) · Springer eBooks · doi:10.1007/978-81-322-2803-5_33
Ferreira, M. D. O. (2015)
Materials of the Congress of Anaesthesiologists of Ukraine September 14–16 2017
України, К. А. (2017) · Pain anesthesia and intensive care · doi:10.25284/2519-2078.3(80).2017.109487
Venlafaxina en el tratamiento del dolor neuropático
Montero, A. A. (2017) · Revista de la Sociedad Española del Dolor · doi:10.20986/resed.2017.3592/2017
The effect of topical neuromodulatory medications on orofacial tissue in vitro
Al‐Musawi, M. (2016)
Physiology and Pathology of Aging
Hategan, A., Bourgeois, J. A., Cheng, T. Z., & Young, J. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-77128-1_1
Medikamente zur Schmerztherapie
Taghizadeh, H., & Benrath, J. (2018) · Springer eBooks · doi:10.1007/978-3-662-55156-1_2
Papel dos macrófagos no gânglio sensitivo na gênese e manutenção da dor neuropática
Guimarães, R. M. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2018.tde-13092018-105246
Kiran, M., Pawaskar, L. J., & Sheikh, S. N. (2019) · International Journal of Innovative Research in Medical Science · doi:10.23958/ijirms/vol04-i01/557
Suponeva, N. A., Белова, Н. В., Zaitseva, N. I., Yusupova, D. G., Lagoda, D. Y., Korepina, O. S., & Пирадов, М. А. (2018) · Human Physiology · doi:10.1134/s0362119718080121
Therapy for Small Fiber Neuropathy
Abuzinadah, A. R., & Gibbons, C. H. (2019) · Springer eBooks · doi:10.1007/978-981-13-3546-4_15
Extraterritorial Heat Hyperalgesia in Mice Following Infraorbital Nerve Transection
Mashregi, M. F. (2017) · TSpace (University of Toronto)
Spithoff, S. M. (2019) · TSpace (University of Toronto)
HTLV-1: A View from the Rheumatologist
Fuentes, A., & Burgos, P. I. (2019) · Springer eBooks · doi:10.1007/978-3-030-23311-2_16
Cavallini, M. C. M. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2019.tde-16102019-105228
Kamrul, R., Bunka, D., Crawley, A., Schuster, B. G., & LeBras, M. H. (2019) · Europe PMC (PubMed Central)
Maher, D. P., Shah, B. J., & Vorobeychik, Y. (2019) · Springer eBooks · doi:10.1007/978-3-030-27447-4_19 · Cited by 2
O envolvimento da O-GlcNacilação no desenvolvimento da dor neuropática
Silva, N. I. Q. E. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2019.tde-04102019-114518
Hutton, H., & Wilmshurst, J. M. (2019) · Journal of the International Child Neurology Association · doi:10.17724/jicna.2019.144
Hefner, G., & Menke, A. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_368-1
Respiratory Failure and Other Respiratory Conditions
Parker-Rajewski, C., Sethi, A., & Abdallah, R. T. (2020) · Springer eBooks · doi:10.1007/978-3-030-40449-9_12 · Cited by 1
Yoon, S. K., & Kim, P. Y. (2020) · Springer eBooks · doi:10.1007/978-3-030-40449-9_15
Opioid Alternative Medication and Clinical Dilemmas
Krazit, S. T. (2020) · Springer eBooks · doi:10.1007/978-3-030-39982-5_22
Management of Chronic Pain: Medication
Hall, B. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-47117-0_6
Methadone in the treatment of bone pain in a patient with disseminated breast cancer
Nosek, K., Leppert, W., Puchała, Ł., Pawlos, A., & Onichimowski, D. (2020) · Palliative Medicine in Practice · doi:10.5603/pmpi.2020.0017
Choosing Wisely Neurology: Recommendations for the Canadian Neurological Society
Beyak, C., Costello, F., Burton, J., & Couillard, P. L. (2020) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2020.210
Cadel, L. (2019) · TSpace (University of Toronto)
Maladkar, M. N., Tekchandani, C. M., & Bajaj, R. K. (2020) · International Journal of Research in Orthopaedics · doi:10.18203/issn.2455-4510.intjresorthop20204615
Pharmacotherapy for Small Fiber Neuropathy
George, T., Kafaie, J., Huang, Z. L., & Profirovic, J. (2020) · Current Treatment Options in Neurology · doi:10.1007/s11940-020-00652-2 · Cited by 1
Opioids for Nonmalignant Chronic Pain
Woodbury, A. (2015) · The AMA Journal of Ethic · doi:10.1001/journalofethics.2015.17.03.ecas1-1503 · Cited by 2
Cannabis in der Schmerztherapie
Cegla, T. H. (2021) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-021-9776-z
Berwertz, M., Das, S., & Raj, J. M. (2021) · Indian Journal of Pain · doi:10.4103/ijpn.ijpn_64_20
Franken, G. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20201203gf
Topical 5% lidocaine patches for treating postherpetic neuralgia: a survey among nurses and patients
Pergolizzi, J. V., Nalamachu, S. R., Mitchell, K., Paladini, A., Taylor, R., & Varrassi, G. (2021) · Signa Vitae · doi:10.22514/sv.2021.114
Cannabinoids as a Substitute for Opioids: Basic Science and Clinical Evidence
MacCallum, C. A., de Freitas, L., Eadie, L., & Narouze, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-69186-8_27
Cannabinoids as a Substitute for Opioids: Suggested Algorithm
Oso, T., Hirani, S., Chung, M. J., Benkli, B., & Le-Short, C. (2021) · Springer eBooks · doi:10.1007/978-3-030-69186-8_28
Plancarte, R., Sámano-García, M., Guillén-Núñez, M. D. R., & Equihua-Ortega, A. (2021) · Gaceta Médica de México · doi:10.24875/gmm.20000810 · Cited by 5
Medical Cannabis in Chronic Pain Management – Where Are We Now?
Haider, S., & Liew, W. (2021) · Indian Journal of Pain · doi:10.4103/ijpn.ijpn_1_21 · Cited by 1
Cannabis thérapeutique : l’expérience canadienne
Beaulieu, P. (2021) · Douleur et Analgésie · doi:10.3166/dea-2021-0164
Fentanyl: Polymorphisms, and adverse events
Benjeddou, M., & Peiró, A. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820589-1.00005-1
Gofton, T. E. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780198837008.003.0024
Evidence-Based Pharmacotherapy of Chronic Pain
Datta, S., & Manchikanti, L. (2018) · Springer eBooks · doi:10.1007/978-3-319-95369-4_24
Adjuvant analgesics: Principles of use
Portenoy, R. K., Ahmed, E., & Patel, M. (2021) · doi:10.1093/med/9780198821328.003.0042
Дельва, М. Ю., Khaustova, O. O., & Зайченко, А. В. (2021) · Неврология и нейрохирургия Восточная Европа · doi:10.34883/pi.2020.10.4.044 · Cited by 1
Martínez, J. P. (2022) · Revista de la Sociedad Española del Dolor · doi:10.20986/resed.2022.4031/2022 · Cited by 1
Stellenwert von Cannabinoiden in der Schmerztherapie
Horlemann, J. (2022) · Schmerzmedizin · doi:10.1007/s00940-022-4011-2
Liu, C. W., & Chong, C. C. W. (2022) · Contemporary rheumatology · doi:10.1007/978-3-031-10687-3_6 · Cited by 2
Antiepileptic medications and antidepressants for neuropathic pain: a meta-analysisPreprint
Li, J., Chunxiang, Z., Yang, Y., & Li, X. (2022) · doi:10.22541/au.166618865.57222662/v1
Hefner, G., & Menke, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_368
Chronic Pain Syndromes: Neck Pain
Deng, G. (2023) · Springer eBooks · doi:10.1007/978-3-031-12998-8_7
Balta, S., & Gültekin, M. Z. (2023) · Clinical and Experimental Health Sciences · doi:10.33808/clinexphealthsci.1078755
Shi, H., Li, H., Fu, X., He, J., & Song, L. (2023) · Research Square · doi:10.21203/rs.3.rs-2896528/v1
Serratus anterior plane block versus intravenous opioid use for acute post-thoracotomy pain
Badawy, F. A., El-Rahman, A., Hassan, K. M., Gad-Allah, A. S.-E. F., & Abdelfattah, K. A. M. (2023) · Research and Opinion in Anesthesia and Intensive Care · doi:10.4103/roaic.roaic_63_22
Consideration of cannabinoids in the treatment of Diabetic Peripheral Neuropathic Pain
Lougheed, T. (2023) · Canadian Diabetes & Endocrinology Today · doi:10.58931/cdet.2023.116
Management of Phantom Limb in Neurorehabilitation
Bhide, R. P., & Barman, A. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316882290.014
Just the facts: the role of gabapentinoids for analgesia in the emergency department
Bhat, C., James, D., & Rosenberg, H. (2023) · Canadian Journal of Emergency Medicine · doi:10.1007/s43678-023-00626-8
Alhassanin, D. H., Elbadry, A. A., Mohamed, N. K., & Ezz, H. A. A. (2023) · International Journal of Medical Anesthesiology · doi:10.33545/26643766.2023.v6.i4a.434
Santis, A. D., Galarraga, F., Acosta, D., Alcarraz, M., Fernández, T., Ferrari, T., Gómez, C., Santos, C., Speranza, N., & Tamosiunas, G. (2023) · Revista Médica del Uruguay · doi:10.29193/rmu.39.2.1
Park, D., Choi, J., & Chang, M. C. (2023) · Journal of Back and Musculoskeletal Rehabilitation · doi:10.3233/bmr-230179
Directive clinique no 445 : Gestion de la douleur pelvienne chronique
Allaire, C., Yong, P. J., Bajzak, K. I., Jarrell, J. F., Lemos, N. L. B. M., Miller, C., Morin, M., Nasr‐Esfahani, M., Singh, S. S., & Chen, I. (2024) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2023.102284
Santos-Garcia, J. B., & Alvarado, J. A. M. (2015) · NeuroTarget · doi:10.47924/neurotarget2015229
Adjunctive Analgesic Pharmaceuticals
Seddighi, R. M. (2024) · Wiley eBooks · doi:10.1002/9781118975169.ch23
Medikamente zur Schmerztherapie
Taghizadeh, H., & Benrath, J. (2024) · Springer eBooks · doi:10.1007/978-3-662-67658-5_2
DeVido, J. J., Hirsch, C. H., Sanger, N., Rosic, T., Samaan, Z., & Bourgeois, J. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-47802-4_16 · Cited by 1
Sumpton, J. E. (2024) · Wiley eBooks · doi:10.1002/9781119645641.ch5 · Cited by 2
Acute pain syndromes in injuries to the nerves and plexuses of the limbs
Dubenko, O. Y., Tovazhnyanska, O., Stepanchenko, K., Zavalna, О. P., & Florikian, V. A. (2024) · ScienceRise Medical Science · doi:10.15587/2519-4798.2024.299496 · Cited by 1
Efficacy of Lidocaine Infusion for Treatment of Chronic Neuropathic Pain: A Case Control Study
Bashir, A., Bary, A., Raza, H., Sher, G., Wasim, T., & Ali, S. M. (2023) · Annals of Punjab Medical College · doi:10.29054/apmc/2023.1353
Nöropatik Ağrıda Farmakolojik Yaklaşımlar
Büyüknacar, H. S., Çiçek, F. A., & Kozan, H. Ç. (2024) · Arşiv Kaynak Tarama Dergisi · doi:10.17827/aktd.1472782 · Cited by 2
Kumar, D. M., Kumar, A., & Singh, A. (2024) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2024.v84i06.016
Decrypting the trends in delivery of drugs to brain for treatment of neuropathy
Sharma, N., Singh, S., Zahoor, I., & Arora, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13474-6.00011-1
Gilron, I. (2024) · Pain · doi:10.1097/j.pain.0000000000003414 · Cited by 1
Self-citationNeuropathic pain: Challenges and solutions in clinical practice
Mitrović, V., Stolic, R. V., & Mitrović, V. (2025) · SANAMED · doi:10.5937/sanamed0-56299
Metadata
- Authors
- Moulin, D., Boulanger, A., Clark, A., Clarke, H., Dao, T., Finley, G., Furlan, A., Gilron, I., Gordon, A., Morley-Forster, P., Sessle, B., Squire, P., Stinson, J., Taenzer, P., Velly, A., Ware, M., Weinberg, E., & Williamson, O.
- Affiliations
- Victoria Hospital (CA)
- Corresponding author
- Moulin, DE
- Venue
- Pain Research and Management
- Publisher
- Wiley
- Published
- 2014-01
- Volume
- 19
- Issue
- 6
- Pages
- 328-335
- ISSN
- 1203-6765 (ISSN-L)
- 1918-1523
- PMC
- PMC4273712
- OpenAlex
- W2206489433
- Cited by
- 529
- References
- 97
- Citations by year
- 2026: 14 · 2025: 14 · 2024: 54 · 2023: 38 · 2022: 38 · 2021: 58 · 2020: 53 · 2019: 53 · 2018: 52 · 2017: 60 · 2016: 50 · 2015: 43
- FWCI
- 34.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pain Research and Management (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship@McGill (McGill) (submittedVersion, cc-by)
- eScholarship@McGill (McGill) (submittedVersion, other-oa)
- Funders
- Neuropathic Pain Special Interest Group of the CPS
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- neuropathic pain, pharmacological management, gabapentinoids, pregabalin, tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, tramadol, controlled-release opioids, cannabinoids, methadone, antiepileptic drugs, tapentadol, botulinum toxin, analgesic combination, stepwise treatment, analgesic efficacy and safety
- MeSH terms
- Analgesics, Canada, Humans, Neuralgia, Chronic Pain, Pain Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.